Compare GLP-1 medicines in Canada
Head-to-head pages: how the medicines differ in what they’re approved for, how they’re taken, side effects, cost and coverage in Canada. Neutral and sourced, never a recommendation: your doctor decides which, if any, fits.
Comparisons
-
Mounjaro vs Ozempic in Canada: what’s the difference?
Mounjaro (tirzepatide) and Ozempic (semaglutide) are different medicines, both approved in Canada for type 2 diabetes, not weight loss. In SURPASS-2,…
-
Rybelsus vs Ozempic in Canada: is the pill the same as the injection?
Yes and no. Rybelsus and Ozempic both contain semaglutide and are approved in Canada for type 2 diabetes, but Rybelsus is a daily tablet taken on an empty…
-
Wegovy vs Ozempic in Canada: what’s the difference?
Wegovy and Ozempic are both semaglutide, a weekly injection from Novo Nordisk. In Canada, Wegovy is approved for weight management at up to 2.4 mg;…
-
Wegovy vs Zepbound in Canada: how do they compare?
Wegovy (semaglutide) and Zepbound (tirzepatide) are both approved in Canada for chronic weight management. In SURMOUNT-5, the head-to-head trial, people…
-
Zepbound vs Mounjaro in Canada: is it the same drug?
Both are tirzepatide in the same 4-dose KwikPens. Mounjaro is approved for type 2 diabetes, Zepbound for weight and sleep apnea. Uses, prices, coverage.